U.S. Food and Drug Administration

Notice: Archived Document
The content in this document is provided on the FDA’s website for reference purposes
only. This content has not been altered or updated since it was archived.

 2001: Purdue
“stopped” false
marketing claims.
Risk management
plan adopted.

May 2007:Purdue
pleads guilty,
pays $600 million
to settle criminal
and civil
litigation, signs
Corporate
Integrity
Agreement with
HHS OIG

Annual U.S. Oxycontin
Prescriptions (Millions)
1/03 FDA Warning Letter about
Illegal Oxycontin promotion

8

6.8 6.4 6.6
6.1
5.6

6

5.7

6.2

4

4

2

1.4

2

Source Rx data: Drug Topics: Compiled by S. Wolfe, FDA DSRM Member

09

20

08

20

07

20

06

20

05

20

04

20

03

20

02

20

01

20

20

00

0

 Annual U.S. Oxycontin
Retail Sales (Billions)

2001: Purdue
“stopped” false
marketing claims.
Risk management
plan adopted.

3.5
3
2.5
2
1.5
1
0.5
0

May 2007: Purdue
pleads guilty, pays
$600 million to
settle criminal and
civil litigation,
signs Corporate
Integrity
Agreement with
HHS OIG

3

1/03 FDA Warning Letter about
Illegal Oxycontin promotion

1.8 1.7
1.6
1.5
1.3
1.1

2.5
1

0.7

*

Source Rx data: Drug Topics: Compiled by S. Wolfe, FDA DSRM Member

09

20

08

20

07

20

06

20

05

20

04

20

03

20

02

20

01

20

20

00

*